Skip to main content
Fig. 7 | Biomarker Research

Fig. 7

From: SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma

Fig. 7

Downregulation of SGOL2 expression promoted apoptosis in vivo. A-B IHC staining of CD34, Ki-67, PCNA, and EMT-related markers. Representative images and quantitative analysis results are shown. C The apoptotic area was dramatically increased in the shSGOL2 group compared with the shNC group. The results are presented as the mean ± SD, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page